India-China Rice Trade Freezes as Beijing Bans Seven Indian Exporters Over GMO Claims

China's General Administration of Customs (GACC) has revoked the export registrations of seven Indian rice exporters, effectively banning them from shipping to China on the grounds of alleged genetically modified organism (GMO) content in their consignments. Three of the seven had already been suspended earlier in 2026; the revocations convert those suspensions into outright bans. The affected companies are headquartered across Chhattisgarh, Karnataka, and Andhra Pradesh.

The GACC action has had an immediate commercial impact. "Rice trade with China has come to a total halt," one affected exporter noted, adding that freight alone accounts for half of consignment costs — making the China route commercially unviable under such regulatory uncertainty. By the end of May this year, China had already rejected at least 70 Indian non-basmati rice consignments on GMO grounds, signalling that the revocations were not isolated incidents.

The central question baffling Indian officials, exporters, and trade analysts is elementary: India does not grow any genetically modified crop commercially, GM paddy included. The Narendra Modi government has formally communicated this position to Beijing. Despite this, GACC has continued to flag GMO presence in Indian shipments.

What makes the Chinese methodology particularly suspicious, industry insiders say, is that a Chinese agency itself clears pre-shipment consignments in India before the cargo is loaded. "How can a consignment cleared by its agency in India suddenly contain GMO when it reaches the destination?" asked one exporter whose registration has been revoked.

Indian officials held talks with GACC counterparts in the third week of May, but Chinese officials offered no explanation of the testing methodology being used to arrive at their findings. The Rice Exporters Association, Chhattisgarh, has since written to APEDA Chairman Abhishek Dev, flagging the rejection of a 520-tonne Swarna white rice consignment — dispatched from Visakhapatnam to Shekou — that had cleared pre-shipment testing in India. "Genetically modified paddy is not approved in India and there is no commercial cultivation of GM paddy in the country," association president Mukesh Jain stated in the letter.

Beyond the immediate export disruption, trade analysts see a calculated strategic dimension to Beijing's actions. One analyst told BusinessLine that China appears to be "finding GMOs in alternate shipments" — a pattern that suggests deliberate selection rather than consistent regulatory enforcement.

The concern is that a sustained GMO narrative, repeated across rejection notices and GACC communications, could erode confidence in Indian rice among buyers in the European Union and other western markets — regions where India's 40 per cent share of global rice trade is most commercially significant. One analyst suggested Beijing may also be attempting to bolster Pakistan's rice export competitiveness by discrediting India in international markets.

"China is building a narrative against India in the global market," the analyst warned, urging the government to publicly challenge the allegation. "The Government must come out to take on this narrative. Otherwise, it could harm our interests. Silence may work in some cases, but it cannot be construed as weakness." Exporters echo this frustration, noting that New Delhi has not openly questioned Beijing's actions despite APEDA having clear-cut shipment procedures in place for rice exports to China.

The scale of what is at risk lends urgency to the dispute. In the 2025-26 season, India exported 21.56 million tonnes (mt) of rice — basmati and non-basmati combined — valued at $11.53 billion, according to data cited by BusinessLine. Global rice trade in the same period was estimated at 59.8 mt, placing India's share at approximately 40 per cent of the world market.

In the current fiscal year, India had already exported over 4 mt of rice valued at $2.03 billion in just the April–May period alone, indicating strong baseline export momentum. The China route, while now entirely frozen, adds freight-heavy logistics costs: one exporter noted that half of a consignment's total cost goes towards freight for the China leg, making the market margin-sensitive even under normal conditions.

Separately, India is preparing to begin cultivation of gene-edited paddy from the upcoming kharif season — a move distinct from GM crop development, as gene editing does not involve inserting foreign genetic material. This distinction, however, may require careful communication to global buyers given the current climate of GMO allegations.